Sex Differences in Clinical Parameters, Pharmacological and Health-Resource Utilization in a Population With

Ana Lear-Claveras1, Bárbara Oliván-Blázquez1,2,3, Ana Clavería3,4,5

  • 1Aragonese Research Group in Primary Care (Grupo Aragonés de Investigación en Atención Primaria/GAIAP), Aragón Health Research Institute, Zaragoza, Spain.

Insights

Hypertension patients experienced minor clinical changes post-lockdown, with lifestyle shifts and healthcare access issues not significantly impacting their health or quality of life. This study tracked clinical and pharmacological parameters in hypertensive individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Nephrology

Background:

  • The COVID-19 pandemic and associated lockdowns significantly altered lifestyles and healthcare access.
  • Understanding the impact on chronic conditions like hypertension is crucial for public health management.

Purpose of the Study:

  • To assess changes in clinical, pharmacological, and healthcare resource utilization in hypertensive patients before and after the COVID-19 lockdown.
  • To evaluate the health outcomes and quality of life in this population, excluding those with COVID-19.

Main Methods:

  • An observational, real-world data study involving 245,979 hypertensive individuals over 16 years old in Aragon, Spain.
  • Analysis of clinical parameters (blood pressure, eGFR, creatinine, lipids), antihypertensive drug use, and healthcare resource utilization.
  • Statistical analysis using Student's T-test and Chi-squared test to compare pre- and post-lockdown periods.

Main Results:

  • A clinically insignificant worsening of systolic blood pressure (SBP), diastolic blood pressure (DBP), renal function, and triglycerides was observed in women.
  • Men showed a lesser degree of worsening in DBP and estimated glomerular filtration rate (eGFR).
  • Antihypertensive drug use and healthcare resource utilization remained below pre-pandemic levels for six months post-lockdown.

Conclusions:

  • Despite lifestyle changes and healthcare access challenges, the health and quality of life of hypertensive patients were not substantially compromised.
  • The findings suggest resilience in this patient group, but continued monitoring is warranted.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
42
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
57
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
806
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
57
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
116
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.4K